Delivery Order SPE2DE24D0013-SPE2D625F8YG4
- Not listed
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- This delivery order, valued at $141,761.80, was awarded to Cepheid Inc. on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of diagnostic reagents and testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by September 15, 2025. Performance will take place at Cepheid's headquarters in Sunnyvale,...
- This delivery order, valued at $40.8K, was awarded to Cepheid Inc. on July 30, 2025, by the Medical Supply Chain office within the Department of Defense. The firm fixed-price contract is for the delivery of molecular diagnostic solutions, specifically supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The work will be performed in Sunnyvale, California, with an ultimate completion date of August 6, 2025. No set-aside designation was applied to this award....
- This delivery order, valued at $13.6K, was awarded on July 21, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, by the Medical Supply Chain within the Department of Defense. The contract, which carries no set-aside designation and employs firm fixed-price terms, is scheduled for completion by July 28, 2025. Based on the contract nomenclature (XPCOV2/FLU/RSV-10), this delivery order pertains to diagnostic testing for COVID-19, influenza, and...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- This delivery order, awarded August 19, 2025, represents a firm fixed-price contract worth $8,160 for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order was issued to Cepheid Inc., a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and reagents for infectious disease detection. Performance will take place at Cepheid's Sunnyvale facility, with an ultimate completion date of August...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8YG4Delivery Order
This delivery order, valued at $6,800, was awarded to Cepheid Inc. on July 28, 2025, for molecular diagnostic solutions related to COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing. The contract operates under a firm fixed-price structure with no set-aside designation and is funded by the Defense Department's Medical Supply Chain organization. Performance will take place at Cepheid's headquarters in Sunnyvale, California. This award is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provide the company with established procurement authority for molecular diagnostic systems, reagents, and testing services across multiple veteran health networks. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with a strong track record of federal contracting across the Veterans Health Administration, Defense Logistics Agency, and Defense Health Agency. The company's existing IDV contracts with the VA include a $32.8 billion single-award vehicle through Veterans Integrated Service Network 6 extending through September 2030, which covers molecular diagnostic testing system reagents and assays. This modest delivery order represents routine procurement activity under Cepheid's established federal vehicle for providing critical diagnostic capabilities to support defense and veterans healthcare testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/28/25 |